---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-022394"
form_type: "8-K"
ticker: "AHCO"
cik: "0001725255"
company_name: "AdaptHealth Corp."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T13:01:25.585157+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AdaptHealth Q1 revenue down 1.8% to $778M; net loss widens; guides FY25 lower on asset sales

## Summary
- Net revenue $777.9M (-1.8% YoY); net loss $7.2M vs $2.1M loss prior year.
- Adjusted EBITDA $127.9M (-19.3% YoY); operating cash flow improved to $95.5M.
- Sold incontinence assets; signed deal to sell infusion assets (closes Q2 2025).
- FY2025 guidance reduced: revenue $3.18B-$3.32B, Adj. EBITDA $665M-$705M.
- Diabetes segment improved for second consecutive quarter.

## SEC filing metadata
- accession: 0001628280-25-022394
- form_type: 8-K
- ticker: AHCO
- cik: 0001725255
- company_name: AdaptHealth Corp.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725255/000162828025022394/0001628280-25-022394-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725255/000162828025022394/ahco-20250506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-022394
- JSON: https://secwatch.observer/filing/0001628280-25-022394.json
- Plain text: https://secwatch.observer/filing/0001628280-25-022394.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.